| Issue Date | Title | Author(s) |
| May-2020 | ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1 | Nowakowski, Grzegorz S.; Zhu, Jun; Zhang, Qingyuan; Brody, Joshua; Sun, Xiuhua; Maly, Joseph; Song, Yuqin; Rizvi, Syed; Song, Yongping; Lansigan, Frederick; Jing, Hongmei; Cao, Junning; Lue, Jennifer K.; Luo, Wen; Zhang, Lei; Li, Ling; Han, Isabel; Sun, Joan; Jivani, Manoj; Liu, Young; Heineman, Thomas; Smith, Stephen D. |
| 2013 | Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group | Kim, Seok Jin; Jung, Hyun Ae; Chuang, Shih-Sung; Hong, Huangming; Guo, Cheng-Cheng; Cao, Junning; Hong, Xiao-Nan; Suzuki, Ritsuro; Kang, Hye Jin; Won, Jong Ho; Chng, Wee-Joo; Kwong, Yok-Lam; Suh, Cheolwon; Song, Yu-Qin; Zhu, Jun; Tay, Kevin; Lim, Soon Thye; Suzumiya, Junji; Lin, Tong-Yu; Kim, Won Seog |
| 8-Nov-2022 | Generation of functionally competent hepatic stellate cells from human stem cells to model liver fibrosis in vitro | Lai, Xinyuan; Li, Chuanyun; Xiang, Chengang; Pan, Zihang; Zhang, Kai; Wang, Lei; Xie, Bingqing; Cao, Junning; Shi, Jihang; Deng, Juan; Lu, Shichun; Deng, Hongkui; Zhuang, Hui; Li, Tong; Shi, Yan; Xiang, Kuanhui |
| Mar-2020 | Generation of human hepatocytes from extended pluripotent stem cells | Wang, Qiming; Sun, Da; Liang, Zhen; Wang, Junyi; Zhong, Xinxing; Lyu, Yulin; Cao, Junning; Lin, Zhongqing; Du, Yuanyuan; Miao, Zhenchuan; Lu, Shichun; Li, Cheng; Xu, Jun; Shi, Yan; Deng, Hongkui |
| 7-Apr-2022 | Hepatitis B Virus Pregenomic RNA Reflecting Viral Replication in Distal Non-tumor Tissues as a Determinant of the Stemness and Recurrence of Hepatocellular Carcinoma | Xiao, Yiwei; Cao, Junning; Zhang, Ze; Zeng, Chaoting; Ou, Guomin; Shi, Jihang; Liu, Zhixiu; Li, Yi; Deng, Juan; Xu, Yinzhe; Zhang, Wenwen; Li, Jie; Li, Tong; Zhuang, Hui; Lu, Shichun; Xiang, Kuanhui |
| 2013 | Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group | Kim, Seok Jin; Hsu, Chiun; Song, Yu-Qin; Tay, Kevin; Hong, Xiao-Nan; Cao, Junning; Kim, Jin Seok; Eom, Hyeon Seok; Lee, Joon Hyeok; Zhu, Jun; Chang, Kian-Meng; Reksodiputro, Arry Harryanto; Tan, Daryl; Goh, Yeow Tee; Lee, Jejung; Intragumtornchai, Tanin; Chng, Wee-Joo; Cheng, Ann-Lii; Lim, Soon Thye; Suh, Cheolwon; Kwong, Yok-Lam; Kim, Won Seog |
| Sep-2023 | Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial | Zhang, Wenwen; Tong, Shuang; Hu, Bingyang; Wan, Tao; Tang, Haowen; Zhao, Feilong; Jiao, Tianyu; Li, Junfeng; Zhang, Ze; Cai, Jinping; Ye, Huiyi; Wang, Zhanbo; Chen, Shiqing; Wang, Yafei; Li, Xuerui; Wang, Fangzhou; Cao, Junning; Tian, Lantian; Zhao, Xiaochen; Chen, Mingyi; Wang, Hongguang; Cai, Shouwang; Hu, Minggen; Bai, Yuezong; Lu, Shichun |
| 2-Nov-2023 | A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas | Song, Yuqin; Li, Zengjun; Wu, Huijing; Jin, Jie; Zhou, Hui; Zhou, Keshu; Zhang, Liling; Peng, Zhigang; Zhang, Zhiye; Cen, Hong; Jia, Youchao; Shuang, Yuerong; Li, Zhiming; Yang, Haiyan; Zou, Liqun; Li, Zhifeng; Zhang, Zhihui; Li, Junmin; Cao, Junning; Qiu, Lugui; Wu, Shaojie; Gong, Tiejun; Xu, Xiaohong; Wang, Zhen; Zhu, Jun |
| 15-Apr-2023 | The Oral PI3Kd Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial | Wang, Tingyu; Sun, Xiuhua; Qiu, Lihua; Su, Hang; Cao, Junning; Li, Zhiming; Song, Yuqin; Zhang, Li; Li, Dengju; Wu, Huijing; Zhang, Wei; Li, Junmin; Zhou, Keshu; Zhou, Hui; Yang, Yu; Li, Zhifeng; Cen, Hong; Cai, Zhen; Zhang, Zhihui; Fu, Weijun; Jin, Jie; Li, Fei; Wu, Weixin; Gu, Xuekui; Zhu, Weiliang; Liu, Lihong; Li, Zengjun; Yi, Shuhua; Bao, Hanying; Xu, Zusheng; Qiu, Lugui |
| 2023 | Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study | Deng, Lijuan; Li, Zhiming; Zhang, Huilai; Huang, Haiwen; Hu, Jianda; Liu, Lihong; Liu, Ting; Jin, Jie; Zhu, Zunmin; Li, Wenyu; Huang, Zhenqian; Huang, Wenrong; Zhou, Keshu; Yang, Haiyan; Zhang, Mingzhi; Ding, Kaiyang; Zhou, Hui; Hu, Yu; Shuang, Yuerong; Cao, Junning; Gao, Sujun; Li, Dengju; Sun, Zimin; Zhang, Qingyuan; Yi, Shuhua; Ji, Chunyan; Zhang, Liansheng; Hou, Cheng; Du, Yue; Wang, Weige; Zhao, Renbin; Song, Yuqin; Zhu, Jun |
| 2-Nov-2023 | Phase 2 Search Study:XPO1 Inhibitor (ATG-010) Monotherapy in Heavily Pretreated Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Song, Yuqin; Cai, Qingqing; Zhang, Qingyuan; Sun, Xiuhua; Yang, Haiyan; Yao, Zhihua; Zou, Liqun; Zhang, Liling; Cao, Junning; Wang, Tingyu; Li, Lanfang; Liu, Yao; Jing, Hongmei; Gao, Sujun; Ding, Kaiyang; Liu, Bingshan; Zhao, Jun; Zhu, Jun |
| Jul-2024 | Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors | Song, Yuqin; Cao, Junning; Zhang, Qingyuan; Li, Caixia; Qiu, Lugui; Qi, Junyuan; Zhang, Huilai; Li, Wenyu; Liu, Lihong; Jing, Hongmei; Zhou, Keshu; Zhang, Weijing; Zhang, Liling; Li, Daqi; Zou, Liqun; Yang, Haiyan; Qian, Wenbin; Zhou, Hui; Hu, Jianda; Yin, Hongyan; Fu, Sisi; Fan, Songhua; Xu, Qian; Wang, Jian; Jia, Xiaoyun; Dai, Guangxiu; Su, Weiguo; Zhu, Jun |
| 20-Apr-2023 | Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial | Song, Yuqin; Tilly, Herve; Rai, Shinya; Zhang, Huilai; Jin, Jie; Goto, Hideki; Terui, Yasuhito; Shin, Ho-Jin; Kim, Won Seog; Cao, Junning; Feng, Jifeng; Eom, Hyeon Seok; Kim, Tae Min; Tsai, Xavier Cheng-Hong; Gau, Jyh-Pyng; Koh, Hideo; Zhang, Liling; Song, Yongping; Yang, Yu; Li, Wei; Huang, He; Ando, Kiyoshi; Sharman, Jeff P.; Sehn, Laurie H.; Bu, Lilian; Wang, Xin; Jiang, Yanwen; Hirata, Jamie; Lee, Calvin; Zhu, Jun; Izutsu, Koji |
| 15-Nov-2022 | Preliminary Biomarker Data from a Phase 1/2 Study of Golidocitinib Demonstrates Targeting JAK/STAT Pathway to Treat Peripheral T-Cell Lymphoma | Song, Yuqin; Kim, Won-Seog; Yoon, Dok-Hyun; Yang, Haiyan; Cao, Junning; Ji, Dongmei; Koh, Youngil; Jing, Hongmei; Eom, Hyeon-Seok; Kwak, Jae-Yong; Lee, Won-Sik; Lee, Jong-Seok; Shin, Ho-Jin; Jin, Jie; Wang, Mei; Li, Jingrun; Zhu, Jun |
| 2018 | Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas | Zhu, Jun; Cao, Junning; Qiu, Lugui; Qi, Junyuan; Song, Yuqin; Tu, Meifeng; Ji, Dongmei; Shen, Weina; Sun, Mingyuan; Hua, Ye; Yang, Chen; Yu, Chen; Wang, Jian; Dai, Guangxiu; Su, Weiguo |
| Nov-2022 | TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity | Tian, Xing; Dong, Huijun; Lai, Xinyuan; Ou, Guomin; Cao, Junning; Shi, Jihang; Xiang, Chengang; Wang, Lei; Zhang, Xuechao; Zhang, Kai; Song, Ji; Deng, Juan; Deng, Hongkui; Lu, Shichun; Zhuang, Hui; Li, Tong; Xiang, Kuanhui |
